PALANDRI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 931
AS - Asia 553
EU - Europa 541
SA - Sud America 71
AF - Africa 14
OC - Oceania 7
Totale 2.117
Nazione #
US - Stati Uniti d'America 922
RU - Federazione Russa 300
CN - Cina 192
SG - Singapore 158
HK - Hong Kong 80
KR - Corea 65
BR - Brasile 64
IE - Irlanda 49
SE - Svezia 47
IT - Italia 41
DE - Germania 36
FI - Finlandia 20
GB - Regno Unito 13
VN - Vietnam 12
IN - India 11
CH - Svizzera 9
FR - Francia 8
ID - Indonesia 8
JO - Giordania 8
AU - Australia 7
CI - Costa d'Avorio 7
TR - Turchia 5
UA - Ucraina 5
BD - Bangladesh 4
JP - Giappone 4
AT - Austria 3
CA - Canada 3
EC - Ecuador 3
MX - Messico 3
NL - Olanda 3
AR - Argentina 2
BJ - Benin 2
DO - Repubblica Dominicana 2
PL - Polonia 2
RO - Romania 2
AL - Albania 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
HN - Honduras 1
IQ - Iraq 1
KE - Kenya 1
KZ - Kazakistan 1
MA - Marocco 1
MM - Myanmar 1
SA - Arabia Saudita 1
SC - Seychelles 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 2.117
Città #
Santa Clara 451
Singapore 130
Ashburn 94
Hefei 71
Hong Kong 67
Seoul 65
Chandler 63
Dublin 49
Beijing 39
Los Angeles 20
Altamura 18
Lawrence 18
Moscow 17
Fairfield 12
Munich 12
Buffalo 11
Princeton 11
Boston 10
Seattle 10
Shanghai 10
Bern 9
Jacksonville 9
Cambridge 8
Jakarta 8
Kent 8
Lappeenranta 8
Woodbridge 8
Abidjan 7
Boardman 7
Melbourne 7
San Diego 7
Washington 7
Wilmington 7
Medford 6
Mumbai 6
São Paulo 6
Belo Horizonte 5
Helsinki 5
Houston 5
London 5
Paris 5
Andover 4
Dallas 4
Frankfurt am Main 4
Izmir 4
Tokyo 4
Turku 4
Bengaluru 3
Bremen 3
Brugherio 3
Falkenstein 3
Hanoi 3
Ho Chi Minh City 3
Lauterbourg 3
The Dalles 3
Vienna 3
Brooklyn 2
Chicago 2
Cotonou 2
Curitiba 2
Düsseldorf 2
Guarulhos 2
Manchester 2
Milan 2
New York 2
Norwalk 2
Osasco 2
Pistoia 2
Rome 2
Salvador 2
Shenzhen 2
Uberlândia 2
Warsaw 2
Almaty 1
Amman 1
Ann Arbor 1
Anápolis 1
Aransas Pass 1
Araçatuba 1
Arnsberg 1
Açu 1
Baghdad 1
Baku 1
Batumi 1
Beuningen 1
Bueno Brandão 1
Bình Tân 1
Bắc Giang 1
Calgary 1
Charlotte 1
Chelmsford 1
Cidade Gaúcha 1
Clifton 1
Colombo 1
Constantine 1
Contagem 1
Delhi 1
Denver 1
Detroit 1
Elk Grove Village 1
Totale 1.433
Nome #
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B 2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 142
A modified adenine chemically coupled to the allergen molecule of Dermatophagoides pteronyssinus redirects allergen-specific Th2 cells 132
Total serum IgE levels influence the in vitro detection of ss-lactams-specific IgE antibodies 125
A modified adenine chemically coupled to allergen molecule(s) induce Interferon-gamma production and down regulate IL-4 and IL-5 in Th2 specific T cells 125
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study 124
Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients 121
Risk-adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosis 119
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19 119
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 116
MPN-375 BET Inhibitor Pelabresib (CPI-0610) Combined With Ruxolitinib in Patients With Myelofibrosis - JAK Inhibitor-Naïe or With Suboptimal Response to Ruxolitinib - Preliminary Data From the MANIFEST Study 113
COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey 113
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib 111
Long-term follow-up of recovered MPN patients with COVID-19 111
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT 110
Incidence of blast phase in myelofibrosis according to anemia severity 109
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT 98
Breakthrough infections in MPN-COVID vaccinated patients 98
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options 71
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial 65
null 15
Totale 2.137
Categoria #
all - tutte 6.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.730


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 5 0 10 2 5 2 3
2021/202254 3 1 3 1 0 0 0 15 1 0 9 21
2022/2023251 18 56 15 17 17 37 26 17 29 5 3 11
2023/2024160 5 11 21 16 15 27 5 37 1 10 3 9
2024/20251.002 16 67 51 118 345 188 19 36 21 20 56 65
2025/2026573 132 170 131 71 69 0 0 0 0 0 0 0
Totale 2.137